Open Access Week: Why open access? Journals and articles
By Kirsty, on 20 October 2020
The open access landscape is ever-changing, and these days it seems as if authors, open access experts, funders and publishers spend a lot of time talking about policies. There’s good reason for that: they’re complicated, and right now lots of them are changing. Since Plan S was announced, funders have begun to introduce policies that’ll help make sure that research is open access as soon as it’s published. We’re going to talk more about policy developments on Thursday, but today we want to go back to basics and ask…
Why open access?
Funders want outputs to be open access on publication. More and more authors are thinking about open access options early on in the publication process – before they submit. They’re telling us that they consider which fully open access journals and journals in UCL’s transformative agreements are suitable, and failing that whether their journal will allow them to make their manuscript open access as soon as it’s published. Why are these changes happening?
Open access advocates, and many authors, have known for a while about the many advantages to making outputs open access, beyond compliance with funders’ policies. The citation-and-visibility advantage is one of the best-established findings in the scholarly communication literature. Open access papers receive more views than their closed counterparts, and they’re cited more often. It’s as simple as that. This applies to all types of open access, whether Gold (open access on publication) or Green – and even where a paper is made open access as long as 12 months after publication, as this recent preprint demonstrates.
This year, though, we’ve seen a dramatic rise in interest in open access, not only in the academic community but from people in all walks of life – and that’s because open access is so vital to combating, or at least helping us to live with, COVID-19. Open access accelerates the rate at which the shared knowledge can be applied, and that’s particularly important in any global health emergency. Previous crises like Ebola in 2014-15, and Zika in 2015-17, highlighted the role of preprints and immediate open access in rapidly developing fields. The WHO in September 2015 announced that timely and transparent pre-publication sharing of data and results during public health emergencies must become the norm across the world.
The new Wellcome open access policy covers preprints in public health emergencies like the current one. Preprints allow data and academic analysis about COVID-19 to be disseminated quickly, without delays caused by reviews and resubmission, and so they allow academics and public health experts to read, develop and challenge the data. Of course, preprints need to be treated with caution, particularly with journalists and politicians being wont to seize on any data that’ll make a headline.
It’s no accident that one of the first things that publishers did in lockdown was to respond to the Wellcome Trust’s call to make temporary changes to their policies to make COVID-19 outputs open access. This has significant health benefits and can impact policies, and we wrote about it here. UCL also launched its COVID-19 research platform that brings together all UCL’s research on the pandemic into one place. The platform currently holds over 700 outputs.
Academics in the Global South are in some ways ahead of the open access game. Access gaps exist between institutions, because of the huge cost of subscriptions. They’re worse still in the Global South. As Peter Suber demonstrates in his 2012 monograph on open access, in 2008, Harvard subscribed to 98,900 serials and Yale to 73,900. At the same time, the best- funded research library in India, at the Indian Institute of Science, subscribed to 10,600. Thus, open access also reduces global inequity and empowers the world’s poorest people to transform their own lives.
As COVID is showing, it’s not just academics and policy-makers who benefit from open access. Open access allows research to be read also by journalists, citizen scientists, patients, health advocates, local government, medical professionals, prospective students – and everyone who needs it.
Why isn’t everything open access by now?
Academic promotion and advancement relies on publications. That’s also how we assess quality, and funding – as part of the REF exercise, and in applications for funding. We know that in the past there’s been too much of an emphasis on where you publish, and not enough on what you publish. That’s gradually changing. UCL has recently launched its new bibliometrics policy, to help academics move away from traditional metrics. It is an important step in supporting the use of Open Science and Scholarship across UCL. This new focus will help researchers to conduct their research in the way that is best for them, and best for the wider research community. Related to this, open access is now part of the promotion process at UCL and is required in applications for research posts.
There’s a long way to go before these new principles, and open access itself, become embedded across disciplines. We haven’t talked much about non-journal outputs, but our colleagues in UCL Press will attest that they’re even more challenging. The landscape is changing, though, and we’re excited to be a part of that change.
Tune in for the rest of the week, especially on Thursday when we’ll talk about how Plan S’s Rights Retention Strategy could give researchers the power to disseminate their research widely, effectively and quickly.